BTA-EG4 is a catalase-amyloid interaction inhibitor, which can significantly enhance the neurotoxicity of amyloid peptides in catalase-overexpressing neuronal cells, and can be used in the study of neurodegenerative diseases.

Product information

CAS Number: 921193-28-4

Molecular Weight: 416.53

Formula: C22H28N2O4S

Chemical Name: 2-(2-(2-(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)ethoxy)ethoxy)ethoxy)ethan-1-ol

Smiles: CC1=CC2SC(=NC=2C=C1)C1C=CC(=CC=1)NCCOCCOCCOCCO

InChiKey: OMNADQKBOIYQPW-UHFFFAOYSA-N

InChi: InChI=1S/C22H28N2O4S/c1-17-2-7-20-21(16-17)29-22(24-20)18-3-5-19(6-4-18)23-8-10-26-12-14-28-15-13-27-11-9-25/h2-7,16,23,25H,8-15H2,1H3

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: To be determined

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.